Last Price
285.10
Today's Change
-6.06 (2.08%)
Day's Change
285.10 - 291.99
Trading Volume
748,936
Market Cap
138 Billion
Shares Outstanding
484 Million
Avg Volume
660,188
Avg Price (50 Days)
303.54
Avg Price (200 Days)
290.63
PE Ratio
36.13
EPS
7.89
Earnings Announcement
12-Feb-2025
Previous Close
291.16
Open
289.85
Day's Range
285.1 - 291.99
Year Range
228.65 - 313.55
Trading Volume
748,936
1 Day Change
-2.08%
5 Day Change
-2.13%
1 Month Change
-7.41%
3 Month Change
-3.42%
6 Month Change
-0.98%
Ytd Change
-1.11%
1 Year Change
13.12%
3 Year Change
-3.18%
5 Year Change
22.00%
10 Year Change
288.21%
Max Change
34387.76%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.